Intraocular Invasion by Conjunctival Squamous Cell Carcinoma: Clinical Presentation, Histopathological Findings, and Outcome.

Anterior chamber Conjunctiva Enucleation Radiotherapy Squamous cell carcinoma

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 10 04 2023
accepted: 05 07 2023
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 16 5 2024
Statut: ppublish

Résumé

Intraocular localization of conjunctival squamous cell carcinoma (SCC) is due to scleral or corneal invasion. Herein, we describe the clinical and histopathological findings in four cases of SCC complicated by intraocular invasion, and we review cases reported in the literature and their management. We retrospectively collected and analyzed clinical characteristics, histopathology, management, and follow-up data from 4 patients with conjunctival SCC complicated by intraocular invasion. We reviewed the literature and summarized cases of intraocular invasion by conjunctival SCC reported over the last 30 years. Two patients presented with intraocular invasion by conjunctival SCC at diagnosis. The two others developed intraocular invasion as recurrence of conjunctival SCC, previously treated with excisional biopsy and adjuvant radiotherapy. All 4 cases had a previous history of conjunctival surgery, but no history of intraocular surgery. Three patients were managed with modified enucleation, including one that required adjuvant orbital radiotherapy. One patient required orbital exenteration. Histopathology analysis showed a well-differentiated conjunctival SCC in all cases. None developed distant localization after at least 2.5-year follow-up. Intraocular invasion is a rare complication of conjunctival SCC. Appropriate treatment in a tertiary center and long-term follow-up are highly recommended.

Identifiants

pubmed: 38751497
doi: 10.1159/000531983
pii: 531983
pmc: PMC11095587
doi:

Types de publication

Journal Article

Langues

eng

Pagination

32-42

Informations de copyright

© 2023 S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Auteurs

Ysé Borella (Y)

Department of Ocular Oncology, Institut Curie, Paris, France.

Livia Lumbroso (L)

Department of Ocular Oncology, Institut Curie, Paris, France.

Christine Lévy (C)

Department of Ocular Oncology, Institut Curie, Paris, France.

Sophie Gardrat (S)

Department of Pathology, Institut Curie, Paris, France.

Jerzy Klijanienko (J)

Department of Pathology, Institut Curie, Paris, France.

Denis Malaise (D)

Department of Ocular Oncology, Institut Curie, Paris, France.
Faculté de médecine, Université Paris Cité, Paris, France.

Rémi Dendale (R)

Department of Radiation Therapy, Institut Curie, Paris, France.

Nathalie Cassoux (N)

Department of Ocular Oncology, Institut Curie, Paris, France.
Faculté de médecine, Université Paris Cité, Paris, France.

Alexandre Matet (A)

Department of Ocular Oncology, Institut Curie, Paris, France.
Faculté de médecine, Université Paris Cité, Paris, France.

Classifications MeSH